PB

Pierrick Bouffaron

Operating Partner @ Main Sequence

Singapore

Invests in

Stages:

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $1,000,000.00
  • Target Investment:

    $250,000.00

Education

Work Experience

  • Operating Partner

    2024

    Working with investment firms and startups to improve their operations and strategy. Investments include Carta, Perplexity, MVHQ, Exchequer, Magma, Maestro, among others. 2024 Fund Advisory BlackRock (infrastructure), Singapore Deep-Tech Alliance (deep tech), Planet Detox Fund (cleantech). 2024 Startup Advisory QSpace (space tech), Solveo (performance), Mindeo (edtech), FlyLab (food tech), Bizsu (cleantech).

2024

  • EVP Corporate Development

    2024

    Moon-focused spacecraft and infrastructure, powered by Airbus. Strategic planning, partnerships and funding.

  • Director, Development & New Ventures

    2020 - 2024

    From labs to markets, and everything in between. Venture building: 7 stealth startups, 3 spinoffs, 1 exit.

2018 - 2020

  • Operating Partner

    2018 - 2020

    Former BA syndicate turned micro VC. Co-founder and lead. Successfully exited to Stallion.

2017 - 2019

  • Director, Head of Acceleration

    2017 - 2019

    Kickstarted Leonard, the group-wide innovation platform. In charge of new ventures, intrapreneurship and CVC.

2015 - 2017

  • Senior Associate

    2015 - 2017

    20+ audits and consulting missions for global clients. VC, corporate innovation and investment strategies.

  • Science & Technology Officer

    2012 - 2015

    Hustler for the French tech and research ecosystems. Public policy, transatlantic partnerships, startup contests.

  • Visiting Research Scholar

    2013 - 2015

    California Institute for Energy and Environment (CIEE). Software-defined building theory and applications.

2010 - 2012

  • Project Manager, Smart Grids

    2010 - 2012

    €30M PV-powered smart grid pilot project: Nice Grid. Publication of a book on district energy system design.

2008 - 2010

  • Chief Operating Officer, SE Asia

    2008 - 2010

    Within the CERIS subsidiary (critical industries). Pharmaceuticals and biotechnology sectors.